Angle Health Raises $200M Series C at $2.7B — Plus a $400M Tender
Vitruvian led Angle Health’s $200M Series C (YC W20) at $2.7B with a $400M tender. Who buys level-funded SMB plans, why profitability matters, and why a European growth firm fits.
Vitruvian led Angle Health’s $200M Series C (YC W20) at $2.7B with a $400M tender. Who buys level-funded SMB plans, why profitability matters, and why a European growth firm fits.
Radical led Mantic’s $25M seed with Balderton, M12, and Thinking Machines Lab after the London forecasting startup beat every human in the Summer 2026 Metaculus Cup — who buys calibrated AI forecasts and why.
Former UP.Labs — now Vantora — took its first outside capital (>$100M, Silversmith) to build AI ventures industrial partners can own. Who uses the studio model and why growth equity fits.
Mazama announced $135 million of new capital including Series B (Axios: funding and grants). Ridgeline closed $250 million Series E at $1.425 billion, Duffield-led. Matter closed Fund II at $450 million. Roundup: Activate $105M, Raindrop Series A (amount undisclosed, $50M total), dtcpay $25M Series A completion.
Matter closed Fund II at $450 million on September 16, 2026. Strategic LPs include ASML, TSMC, and Kleiner Perkins. Founding partner Wen Hsieh spent 17 years at Kleiner. Directory overlap: Eridu. Do not mix Fund II with Rhoda’s $450M Series A.
Ridgeline raised $250 million Series E on September 16, 2026 at $1.425 billion, led by founder Dave Duffield. Customers invested. Company claims $750B AUM/AUA on the platform. Bloomberg printed $1.4B. Not Memphis Ridgeline Ventures. No revenue print.